# INDOMETHACIN
> **ANDA204853** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2017-05-08
## Drug
- **FDA Application Number:** ANDA204853
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** INDOMETHACIN
- **Generic name:** Indomethacin
- **Active ingredients:** INDOMETHACIN
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **First approval:** 2017-05-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204853)
---
*MORVS · CC0 1.0*